An AI-guided method improves intra-arterial therapy by mapping all tumor-feeding arteries to enhance delivery accuracy in malignant brain tumor treatment.
Key Details
- 1Technique was developed and tested by MD Anderson Cancer Center researchers.
- 2AI identifies all blood vessels feeding a brain tumor using imaging.
- 3Allows for multi-pedicle, not just single-artery, delivery of intra-arterial therapy.
- 4Multi-pedicle approach covered >85% of tumors vs. <65% with single-pedicle infusion.
- 5Tested in 3 patients, shown to reduce off-target therapy and enable potential repeatability.
- 6Presented at the SNIS 23rd Annual Meeting; further studies are needed for outcomes.
Why It Matters
Precise targeting of tumor vasculature could optimize therapeutic exposure and minimize side effects in difficult-to-treat brain tumors. This AI-driven approach exemplifies the evolving role of advanced imaging and AI in interventional radiology and neuro-oncology innovation.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.